Quantum Blue® Infliximab - BUHLMANN - Rapid Test

Quantum Blue® Infliximab


Quantum Blue® Infliximab

BÜHLMANN Quantum Blue®Infliximab is for Research Use Only in the US.

Infliximab Trough Level
Over the past two decades great improvements in therapy of chronic inflammatory diseases have been made. The rise of TNFα biologics like infliximab has been a great step forward to ameliorating disease course and keep inflammations at remission levels for prolonged periods of time. Subjects with suboptimal drug concentrations have worse outcomes than those with adequate drug levels. Therapeutic drug monitoring (TDM) for infliximab has a great potential for the management of anti TNF therapy.

Studies have shown that targeting an adequate infliximab trough level can support guidance of treatment in IBD. An optimal therapeutic window for trough levels seem to be the range from 3 to 7 µg/mL of infliximab in serum (Casteele et al., Gastroenterology, 2015).

Quantum Blue® Infliximab:

  • … is the first rapid test to measure infliximab in serum samples. The test is designed for the selective measurement of infliximab by a sandwich immunoassay.
  • … measures from 0.4 to 20 µg/mL. The target concentrations for trough level interpretation lies well within the linear range of the test.
  • … provides a quantitative result within 15 minutes of incubation time. This offers the possibility to health care providers to act immediately before infusion of the next infliximab dose.
  • … is unique in the diagnostics market, being the only test that can provide fast, reliable TDM for infliximab and it correlates well with the standard routine ELISAs for infliximab level determinations.

The Quantum Blue® Infliximab assay measures from 0.4 to 20 µg/ml, and the target concentrations lies well within the linear range of the test. Quantum Blue® Infliximab provides a quantitative result within 15 minutes of incubation time. Quantum Blue® Infliximab is unique, being the only test that can provide fast, reliable information for infliximab, and correlating well with the standard routine ELISAs for determination of infliximab levels.

Quantum Blue® Infliximab Product Information

Test Quantum Blue® Infliximab
Method Lateral Flow
Time to Result 15 min (approx.)
Sample Type Serum
Measuring Range 0.4-20 µg/ml
Catalog Number see below

Download IFU and Catalog Numbers

View the appropriate tab below and click on the blue underlined catalog number to view the Instructions for Use.

Quantum Blue® Reader 3rd Generation-
•   BI-POCTR-ABS- Reader User Manual [EN]
•    Quick Guide – Fail Safe Mode [EN]
•    Quick Guide – Fast Track Mode [EN]

Quantum Blue® Reader 2nd Generation User Manual-
•   BI-POCTR-ABS- Reader User Manual [EN]

Related Quantum Blue® assays:

BÜHLMANN Quantum Blue® fCAL High RangeLF-CHR25-U
BÜHLMANN Quantum Blue® fCAL extendedLF-CALE25-U
BÜHLMANN Quantum Blue® AdalimumabLF-TLAD25-U/LF-TLAD10-U
BÜHLMANN Quantum Blue® Anti-Adalimumab – LF-ADAD25-U/LF-ADAD10-U
BÜHLMANN Quantum Blue® Infliximab – LF-TLIF25/LF-TLIF10
BÜHLMANN Quantum Blue® Anti-Infliximab – LF-ADIF25-U/LF-ADIF10-U

BÜHLMANN Products are distributed in Canada by Inter Medico.  For more information, email info@inter-medico.com or call 1.800.387.9643.

Infliximab Flyer for US [EN]

Infliximab Flyer for Canada [EN]

Infliximab Flyer [FR] (coming soon)

TDM Pipeline Flyer [EN] (coming soon)

Product Highlights
Learn more about the analyte, the advantages of the assay, and other interesting information related to this product.
News and Events
Visit our News page to learn about upcoming events, the latest news about new products, studies and BÜHLMANN in general.
View Citations
Learn about new publications citing use of our products in a variety of studies, applications, and fields of research.
Visit our contact page to enter your requests for quotations or to submit an order inquiry.